Mar M. Sanchez is a Professor in the Department of Psychiatry & Behavioral Sciences, Emory University School of Medicine, and Core Scientist and Chief of the Division of Developmental and Cognitive Neuroscience, Emory National Primate Research Center, Emory University. She received her Ph.D. in Neurobiology and Cell Biology from the Complutense University of Madrid, Spain, and has expertise in stress neurobiology and behavioral neuroscience. Her lab studies the neurobiology of stress and
emotional regulation using nonhuman primate models. Her main research focus is to understand how early life stress (ELS) affects the development of brain circuits that control emotional and stress reactivity from infancy through adolescence, leading to increased risk of psychiatric disorders, including anxiety, depression, and drug addiction. She uses a multidisciplinary approach, including analysis of neuroendocrine stress systems, social and emotional behavior, and brain development using in vivo neuroimaging techniques (MRI, DTI, PET, and resting state fMRI) and in vitro assays of brain neuropeptide and corticosteroid systems. Her research program is supported by NIH and NSF funding and by awards from private foundations (e.g., NARSAD).
Mar M. Sanchez is a Professor in the Department of Psychiatry & Behavioral Sciences, Emory University School of Medicine, and Core Scientist and Chief of the Division of Developmental and Cognitive Neuroscience, Emory National Primate Research Center, Emory University. She received her Ph.D. in Neurobiology and Cell Biology from the Complutense University of Madrid, Spain, and has expertise in stress neurobiology and behavioral neuroscience. Her lab studies the neurobiology of stress and
emotional regulation using nonhuman primate models. Her main research focus is to understand how early life stress (ELS) affects the development of brain circuits that control emotional and stress reactivity from infancy through adolescence, leading to increased risk of psychiatric disorders, including anxiety, depression, and drug addiction. She uses a multidisciplinary approach, including analysis of neuroendocrine stress systems, social and emotional behavior, and brain development using in vivo neuroimaging techniques (MRI, DTI, PET, and resting state fMRI) and in vitro assays of brain neuropeptide and corticosteroid systems. Her research program is supported by NIH and NSF funding and by awards from private foundations (e.g., NARSAD).